These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15669557)

  • 1. Is the elevated breast cancer risk observed in the WHI study an artifact?
    Kuhl H
    Climacteric; 2004 Sep; 7(3):319-22. PubMed ID: 15669557
    [No Abstract]   [Full Text] [Related]  

  • 2. HRT, HERS, NIH, WHI: alphabet soup?
    Legato MJ
    J Gend Specif Med; 2002; 5(6):10-3. PubMed ID: 12503220
    [No Abstract]   [Full Text] [Related]  

  • 3. The Women's Health Initiative study: perspectives and implications for clinical practice.
    Hammond CB
    Rev Endocr Metab Disord; 2005 May; 6(2):93-9. PubMed ID: 15843880
    [No Abstract]   [Full Text] [Related]  

  • 4. Timing of hormone therapy influences breast cancer risk.
    Harv Womens Health Watch; 2011 Apr; 18(8):7. PubMed ID: 21544975
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent epidemiological evidence relevant to the clinical management of the menopause.
    Shapiro S
    Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WHI, WHI, WHI?
    MacLennan AH; Sturdee DW
    Climacteric; 2004 Sep; 7(3):221-4. PubMed ID: 15669545
    [No Abstract]   [Full Text] [Related]  

  • 7. Current controversies about combined hormone therapy and the relative risks to the breast and endometrium.
    Ulrich LG
    Climacteric; 2004 Sep; 7(3):229-37. PubMed ID: 15669547
    [No Abstract]   [Full Text] [Related]  

  • 8. Invited commentary: Postmenopausal unopposed estrogen and breast cancer risk in the Women's Health Initiative--before and beyond.
    Linet MS
    Am J Epidemiol; 2008 Jun; 167(12):1416-20. PubMed ID: 18448443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A personal initiative for women's health: to challenge the Women's Health Initiative.
    Genazzani AR; Gambacciani M
    Gynecol Endocrinol; 2002 Aug; 16(4):255-7. PubMed ID: 12396552
    [No Abstract]   [Full Text] [Related]  

  • 10. A clinician's review of the WHI-related literature.
    Speroff L
    Int J Fertil Womens Med; 2004; 49(6):252-67. PubMed ID: 15751264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
    Grant EC
    J Natl Cancer Inst; 2011 Jul; 103(13):1069; reply 1069-70. PubMed ID: 21700925
    [No Abstract]   [Full Text] [Related]  

  • 12. HRT and breast cancer: recent findings in the context of the evidence to date.
    Banks E; Canfell K; Reeves G
    Womens Health (Lond); 2008 Sep; 4(5):427-31. PubMed ID: 19072480
    [No Abstract]   [Full Text] [Related]  

  • 13. The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.
    Lemay A
    J Obstet Gynaecol Can; 2002 Sep; 24(9):711-5. PubMed ID: 12360366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The breast cancer "plunge" after initial publication of the WHI results: an alternative explanation.
    Simon JA; Nahum GG; Stanislaw H; Gaines T
    Maturitas; 2010 Jul; 66(3):277-84. PubMed ID: 20471761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health risks after cessation of postmenopausal hormone therapy.
    Pines A; Sturdee D; Birkhäuser M;
    Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782
    [No Abstract]   [Full Text] [Related]  

  • 16. Postmenopausal hormone therapy and breast cancer: a clinician's message for patients.
    Speroff L
    Endocrine; 2004 Aug; 24(3):211-6. PubMed ID: 15542887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement and breast cancer: implications of the Iowa Women's Health Study.
    Mayer ME
    Cleve Clin J Med; 1999; 66(10):608-10, 613. PubMed ID: 10598365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women's Health Initiative study.
    Bhavnani B
    J Obstet Gynaecol Can; 2002 Sep; 24(9):689-90. PubMed ID: 12360361
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormone replacement therapy: where do we go now?
    Kaunitz AM
    Breast J; 2002; 8(6):329-31. PubMed ID: 12390354
    [No Abstract]   [Full Text] [Related]  

  • 20. Progestogens and breast cancer risk: the role of hormonal contraceptives and hormone replacement therapy.
    Marsden J; A'Hern R
    J Fam Plann Reprod Health Care; 2003 Oct; 29(4):185-7. PubMed ID: 14662049
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.